Flowcytometric and DNA Analysis Minimal Residual Disease (MRD) in Childhood B-Lineage lymphoblastic leukemia

Flowcytometric and DNA Analysis Minimal Residual Disease (MRD) in Childhood B-Lineage lymphoblastic leukemia

Background: Induction Chemotherapy for Acute Lymphoblastic Leukemia achieves complete remis&not;sion in over 90% of children. It is apparent therefore that many patients in clinical remission and with&not;out residual disease detectable by conventional light microscopy of peripheral...

Full description

Bibliographic Details
Main Authors:	Vossough P, Faranoush M, Emami Z, Bahoush Gh, Arjmandi Kh, Ansari Sh, Alebouyeh M, Shahgholi E, Hedayatiasl A.A
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2005-07-01
Series:	International Journal of Hematology-Oncology and Stem Cell Research
Subjects:	Minimal Residual Disease DNA analysis
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/4525.pdf&manuscript_id=4525

Similar Items

Flowcytometric and DNA Analysis Minimal Residual Disease (MRD) in Childhood B-Lineage lymphoblastic leukemia
by: P Vossough, et al.
Published: (2005-06-01)

Study of D/G Hemoglobin incidence in a sample population (single institution)
by: Kh Arjmandi, et al.
Published: (2005-03-01)

Study of D/G Hemoglobin incidence in a sample population (single institution)
by: Kh.Arjmandi M. Faranoush Gh. Bahoush P. Vossough AA. Hedayatiasl Sh.Ansari E. Shahgholi
Published: (2005-06-01)

Mesenchymal Stem Cell Therapy for Multiple Sclerosis
by: Vossough P, et al.
Published: (2005-07-01)

AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AML
by: Diana Hanekamp, et al.
Published: (2021-05-01)

Consensus Recommendations for MRD Testing in Adult B-Cell Acute Lymphoblastic Leukemia in Ontario
by: Anne Tierens, et al.
Published: (2021-03-01)

Clinical significance of the achievement of MRD-negativity in patients with chronic lymphocytic leukemia
by: Yu V Mirolyubova, et al.
Published: (2018-03-01)

Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances
by: Cumbo C, et al.
Published: (2020-05-01)

Minimal residual disease assessment in acute lymphoblastic leukemia by 4-color flow cytometry: Recommendations from the MRD Working Group of the Brazilian Society of Bone Marrow Transplantation
by: Maura R.V. Ikoma-Colturato, et al.
Published: (2021-07-01)

Outcomes and impact of minimal residual disease (MRD) in pediatric, adolescent and young adults (AYA) with acute lymphoblastic leukemia treated with modified MCP 841 protocol
by: Avinash Pandey, et al.
Published: (2020-01-01)

Permanent Consequences in Langerhans Cell Histiocytosis Single Center Study
by: Kh Arjmandi Rafsanjani, et al.
Published: (2005-09-01)

Permanent Consequences in Langerhans Cell Histiocytosis Single Center Study
by: Arjmandi Rafsanjani Kh., et al.
Published: (2005-09-01)

Correlation of cytomorphology with flowcytometric immunophenotyping in acute myeloid leukemia
by: Selicean Elena-Cristina, et al.
Published: (2013-09-01)

Evaluation of Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Using EuroFlow Approaches
by: OA Beznos, et al.
Published: (2017-04-01)

Diagnosis of Acute Lymphoblastic Leukemia Originating From T-Lineage Precursors and Approaches to Minimal Residual Disease Monitoring
by: OA Chernysheva, et al.
Published: (2018-12-01)

Significance of Neuropilin-1 (CD 304) Expression in Paediatric B- Lineage Acute Lymphoblastic Leukemia (ALL)
by: Moizza Sahar, et al.
Published: (2019-05-01)

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study
by: Houli Zhao, et al.
Published: (2020-05-01)

PCR-based MRD testing for acute lymphoblastic leukaemia in India
by: Rubina Islam, et al.
Published: (2017-01-01)

Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)
by: Nagafuji Koji, et al.
Published: (2013-02-01)

Minimal Residual Disease Detection in Pediatric Acute Lymphoblastic Leukemia
by: Miyoung Kim, et al.
Published: (2020-10-01)

Monitoring of T-cell acute lymphoblastic leukemia by flow cytometry
by: Janeliūnienė Miglė, et al.
Published: (2010-12-01)

Assessment of minimal residual disease in childhood acute lymphoblastic leukemia
by: Sonia K Parikh, et al.
Published: (2016-01-01)

CDX2 gene expression in acute lymphoblastic leukemia
by: Hanaa H. Arnaoaut, et al.
Published: (2014-06-01)

SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?
by: Cristina Turcas, et al.
Published: (2020-06-01)

An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemia
by: Nikhil Patkar, et al.
Published: (2017-01-01)

Leukemia-associated immunophenotype of tumor cells in childhood B-precursors acute lymphoblastic leukemia
by: L. V. Movchan
Published: (2014-07-01)

Leukemia-associated immunophenotype of tumor cells in childhood B-precursors acute lymphoblastic leukemia
by: L. V. Movchan
Published: (2014-07-01)

Minimal residual disease program for acute lymphoblastic leukemia at Dhahran Health Center
by: Nasir Khalid Amra, et al.
Published: (2016-01-01)

Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia
by: Irene Della Starza, et al.
Published: (2021-03-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-09-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-07-01)

Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment
by: Katharina Kriegsmann, et al.
Published: (2020-08-01)

Pediatric acute lymphoblastic leukemia treatment protocols improvement: emphasis on minimal residual disease
by: M. A. Shervashidze, et al.
Published: (2020-10-01)

Next-Generation Sequencing in Acute Lymphoblastic Leukemia
by: Nicoletta Coccaro, et al.
Published: (2019-06-01)

Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR)
by: Weber Axel, et al.
Published: (2012-11-01)

Clinical Staging and Flowcytometric CD38 and Zap-70 Prognostic Indicators in Sudanese Patients with Chronic Lymphocytic Leukemia
by: Enaam Abdelrhman Abdelgader, et al.
Published: (2020-03-01)

VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma
by: Nadiminti K, et al.
Published: (2017-01-01)

Vergleichende Analyse von Antigenexpressionsmustern kindlicher cALL-Blasten und gesunden B-Zellvorstufen – Nutzen für die MRD Diagnostik
by: Hempel, Katharina
Published: (2019)

Severe Hypercalcemia: A Rare and Unusual Presentation of Childhood Acute Lymphoblastic Leukemia
by: Gholamreza Bahoush, et al.
Published: (2014-06-01)

Mucocutaneous Relapse as an Unusual Presentation of T-Lineage Acute Lymphoblastic Leukemia
by: Mahdi Shahriari, et al.
Published: (2016-01-01)

Cannot write session to /tmp/vufind_sessions/sess_rtanclm5pfmnr55c059qbtt4mu